With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.
Read More
About 33,000 passengers from the U.K. had arrived at various airports in India between November 25 and December 23. Of
Read More
The new variant was first identified in Kent and Greater London in end-September. The preliminary assessment of outcomes of hospitalisation
Read More
This is the first time a vaccine to be administered outside the universal immunisation programme and specifically for adults is to be rolled out. Since several aspects of the COVID vaccination programme are new, the government has rightly decided to undertake a dry-run for vaccine administration.
Read More
The number of daily fresh coronavirus cases has been steadily dropping from a peak of nearly 98,000 cases on September 16 to below 25,000 daily cases in the last few days with no spike seen nationally. The cases have been reducing despite the festival season, winter, large gatherings and not so good adherence to non-pharmaceutical interventions. However, the cumulative test positivity rate nationally is 6.1% as on December 23, which suggests we aren’t near the end of the first wave immediately.
Read More
Of the many mutations found in the variant, the scientists have pointed out that the N501Y mutation increases the transmissibility
Read More
According to a preliminary report posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant
Read More
On Saturday, the UK imposed strict restrictions in greater London and much of the southeast of England to stop the spread
Read More
Unlike in other groups, national databases of people with comorbidities are not available. However, though not comprehensive, since 2010, State
Read More
Meanwhile, the Indian government has spelt out four high-risk groups — healthcare workers, frontline workers, those over 50 years of
Read More
The greatly reassuring decision to seek additional safety and immunogenicity data from the Pune-based Serum Institute of India and Hyderabad’s
Read More
Unlike Pfizer, AstraZeneca, which is carrying out the phase-3 trials of the Oxford vaccine in four countries, is yet to
Read More
But the government’s idea of vaccinating a “critical mass of people” for the purpose of breaking the virus transmission chain
Read More